State of the art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?

Respiratory Research

Volumn 4, Issue , 2003, Pages

  Chmiel, James F ^a   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Inflammation; Lung; Pseudomonas aeruginosa

Indexed keywords

ELASTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; LEUKOTRIENE B4; NITRIC OXIDE;

AIRWAY OBSTRUCTION; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CLINICAL FEATURE; CYSTIC FIBROSIS; EPITHELIUM CELL; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; INFECTION CONTROL; INFECTION SENSITIVITY; LIPOGENESIS; LUNG INFECTION; LUNG INFILTRATE; MICROENVIRONMENT; MUCOCILIARY CLEARANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW; BACTERIAL INFECTION; LUNG DISEASE; MICROBIOLOGY; PATHOPHYSIOLOGY; PNEUMONIA;

BACTERIAL INFECTIONS; CYSTIC FIBROSIS; HUMANS; LUNG DISEASES; PNEUMONIA;

EID: 1542267080     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-4-8     Document Type: Review

References (97)

1. Davis PB, Drumm ML and Konstan MW: State of the Art: Cystic Fibrosis. Am J Resp Crit Care Med 1996, 154: 1229-1256.
2. Lloyd-Still JD: Crohn's disease and cystic fibrosis. Dig Dis Sci 1994, 39: 880-885.
3. Taylor CJ and Aswani N: The pancreas in cystic fibrosis. Paediatr Respir Rev 2002, 3: 77-81.
4. Pilewski JM and Frizzell RA: Role of CFTR in airway disease. Physiol Rev 1999, 79(1 Suppl): S215-S255.
5. Fang X, Fukuda N, Barbry P, Sartori C, Verkman AS and Matthay MA: Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J Gen Physiol 2002, 119: 199-207.
6. Bubien JK: CFTR may play a role in regulated secretion by lymphocytes: a new hypothesis for the pathophysiology of cystic fibrosis. Pflugers Arch 2001, 443(Suppl 1): S36-S39.
7. Tarran R, Loewen ME, Paradiso AM, Olsen JC, Gray MA, Argent BE, Boucher RC and Gabriel SE: Regulation of Murine Airway Surface Liquid Volume by CFTR and Ca(2+)-activated Cl(-) Conductances. J Gen Physiol 2002, 120: 407-418.
8. Greger R, Mall M, Bleich M, Ecke D, Warth R, Riedemann N and Kunzelmann K: Regulation of epithelial ion channels by the cystic fibrosis transmembrane conductance regulator. J Mol Med 1996, 74: 527-534.
9. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R and Rossier BC: Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996, 12: 325-328.
10. Kunzelmann K, Schreiber R, Nitschke R and Mall M: Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator. Pflugers Arch 2000, 440: 193-201.
11. Jiang Q, Li J, Dubroff R, Ahn YJ, Foskett JK, Engelhardt J and Kleyman TR: Epithelial sodium channels regulate cystic fibrosis transmembrane conductance regulator chloride channels in Xenopus oocytes. J Biol Chem 2000, 275: 13266-13274.
12. Briel M, Greger R and Kunzelmann K: Cl-transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC. J Physiol 1998, 508(Pt 3): 825-836.
13. Stutts MJ, Rossier BC and Boucher RC: Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem 1997, 272: 14037-14040.
14. Zahm JM, Baconnais S, Davidson DJ, Webb S, Dorin J, Bonnet N, Balossier G and Puchelle E: X-ray microanalysis of airway surface liquid collected in cystic fibrosis mice. Am J Physiol Lung Cell Mol Physiol 2001, 281: L309-L313.
15. Jayaraman S, Joo NS, Reitz B, Wine JJ and Verkman AS: Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci U S A 2001, 98: 8119-8123.
16. Jayaraman S, Song Y, Vetrivel L, Shankar L and Verkman AS: Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. J Clin Invest 2001, 107: 317-324.
17. Matsui H, Davis CW, Tarran R and Boucher RC: Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia. J Clin Invest 2000, 105: 1419-1427.
18. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW and Boucher RC: Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998, 95: 1005-1015.
19. Kopito LE, Kosasky HJ and Shwachman H: Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertil Steril 1973, 24: 512-516.
20. King M: Experimental models for studying mucociliary clearance. Eur Respir J 1998, 11: 222-228.
21. Atsuta S and Majima Y: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus. Ann Otol Rhinol Laryngol 1998, 107: 47-51.
22. Sturgess J and Imrie J: Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am J Pathol 1982, 106: 303-311.
23. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B and Puchelle E: Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000, 23: 121-127.
24. Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E and Jacquot J: Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998, 153: 921-930.
25. Kelley TJ and Drumm ML: Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998, 102: 1200-1207.
26. Kelley TJ and Elmer HL: In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J Clin Invest 2000, 106: 403-410.
27. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR and Goldberg JB: Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996, 271: 64-67.
28. Saiman L and Prince A: Pseudomonas aeruginosa pili bind to asialoGM1, which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 1993, 92: 1875-1880.
29. Saiman L, Cacalano G, Gruenert D and Prince A: Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun 1992, 60: 2808-2814.
30. Baltimore RS, Christie CD and Smith GJ: Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989, 140: 1650-1661.
31. Ulrich M, Herbert S, Berger J, Bellon G, Louis D, Munker G and Doring G: Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence. Am J Respir Cell Mol Biol 1998, 19: 83-91.
32. Sajjan U, Corey M, Humar A, Tullis E, Cutz E, Ackerley C and Forstner J: Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol 2001, 50: 535-546.
33. Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A, Weber PP, Colledge WH, Evans MJ, Geddes DM and Alton EW: Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001, 17: 27-35.
34. DiMango E, Ratner AJ, Bryan R, Tabibi S and Prince A: Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998, 101: 2598-2605.
35. DiMango E, Zar HJ, Bryan R and Prince A: Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995, 96: 2204-2210.
36. Arora SK, Ritchings BW, Almira EC, Lory S and Ramphal R: The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun 1998, 66: 1000-1007.
37. Ramphal R, Arora SK and Ritchings BW: Recognition of mucin by the adhesin-flagellar system of Pseudomonas aeruginosa. Am J Respir Crit Care Med 1996, 154(4 Pt 2): S170-S174.
38. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H and Prince A: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998, 66: 43-51.
39. Bauernfeind A, Bertele RM, Harms K, Horl G, Jungwirth R, Petermuller C, Przyklenk B and Weisslein-Pfister C: Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987, 15: 270-277.
40. Gilligan PH: Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991, 4: 35-51.
41. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B and Wagener J: Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999, 28(2): 321-328.
42. Pitt TL: Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med 1986, 79(Suppl 12): 13-18.
43. Poole K: Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 2001, 3: 255-264.
44. Oliver A, Canton R, Campo P, Baquero F and Blazquez J: High Frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288: 1251-1254.
45. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC and Doring G: Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109: 317-325.
46. Vasil ML: Pseudomonas aeruginosa : biology, mechanisms of virulence, epidemiology. J Pediatr 1986, 108(5 Pt 2): 800-805.
47. Pier GB and Elcock ME: Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J Immunol 1984, 133: 734-739.
48. Pier GB, Takeda S, Grout M and Markham RB: Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. J Clin Invest 1993, 91: 1079-1087.
49. Marshall BC and Carroll KC: Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis. Semin Respir Infect 1991, 6: 11-18.
50. Boyd A and Chakrabarty AM: Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 1994, 60: 2355-2359.
51. Burke V, Robinson JO, Richardson CJ and Bundell CS: Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis. Pathology 1991, 23: 145-148.
52. Demko CA, Byard PJ and Davis PB: Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995, 48: 1041-1049.
53. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M and Miller SI: Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286: 1561-1565.
54. Bainbridge T and Fick RB Jr: Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J Lab Clin Med 1989, 114: 728-733.
55. Wretlind B and Pavlovskis OR: Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis 1983, 5(Suppl): S998-S1004.
56. Klinger JD, Tandler B, Liedtke CM and Boat TF: Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium. J Clin Invest 1984, 74: 1669-1678.
57. Williams JC, Lucas BJ, Knee C, Renzetti M and Donahue J: Acute lung injury induced by Pseudomonas aeruginosa elastase in hamsters. Exp Lung Res 1992, 18: 155-171.
58. Wieland CW, Siegmund B, Senaldi G, Vasil ML, Dinarello CA and Fantuzzi G: Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. Infect Immun 2002, 70: 1352-1358.
59. Frank DW: The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997, 26: 621-629.
60. Bruno TF, Buser DE, Syme RM, Woods DE and Mody CH: Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect Immun 1998, 66: 3072-3079.
61. Baker NR, Minor V, Deal C, Shahrabadi MS, Simpson DA and Woods DE: Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun 1991, 59: 2859-2863.
62. Barbieri JT: Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin. Int J Med Microbiol 2000, 290: 381-387.
63. Herard AL, Pierrot D, Hinnrasky J, Kaplan H, Sheppard D, Puchelle E and Zahm JM: Fibronectin and its alpha 5 beta 1-integrin receptor are involved in the wound-repair process of airway epithelium. Am J Physiol 1996, 271: L726-733.
64. Krall R, Sun J, Pederson KJ and Barbieri JT: In vivo rho GTPase- activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun 2002, 70: 360-367.
65. Cox CD: Role of pyocyanin in the acquisition of iron from transferrin. Infect Immun 1986, 52: 263-270.
66. Wilson R, Pitt T, Taylor G, Watson D, MacDermot J, Sykes D, Roberts D and Cole P: Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest 1987, 79: 221-229.
67. Grimwood K, Semple RA, Rabin HR, Sokol PA and Woods DE: Elevated exoenzyme expression by P. aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol 1993, 15: 135-139.
68. Jaffar-Bandjee MC, Lazdunski A, Bally M, Carrere J, Chazalette JP and Galabert C: Production of elastase, exotoxin A and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 1995, 33: 924-929.
69. Donlan RM and Costerton JW: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15: 167-193.
70. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ and Greenberg EP: Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407: 762-764.
71. Drenkard E and Ausubel FM: Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002, 416: 740-743.
72. Equi A, Balfour-Lynn I, Bush A and Rosenthal M: Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002, 360: 978.
73. Wolter J, Seeney S, Bell S, Bowler S, Masel P and McCormack J: Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002, 57: 212-216.
74. Coenye T, Vandamme P, Govan JR and LiPuma JJ: Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 2001, 39: 3427-3436.
75. LiPuma JJ: Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998, 19: 473-486.
76. Zughaier SM, Ryley HC and Jackson SK: Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 1999, 67: 1505-1507.
77. Hughes JE, Stewart J, Barclay GR and Govan JR: Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 1997, 65: 4281-4287.
78. Hendry J, Elborn JS, Nixon L, Shale DJ and Webb AK: Cystic fibrosis: Inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Eur Respir J 1999, 14: 435-438.
79. Noah TL, Black HR, Cheng PW, Wood RE and Leigh MW: Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997, 175: 638-647.
80. Muhlebach MS, Stewart PW, Leigh MW and Noah TL: Quantitation of inflammatory response to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999, 160: 186-191.
81. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ and Riches DWH: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151: 1075-1082.
82. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF and Phelan PD: Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156: 1197-1204.
83. Bonfield TL, Panuska JR, Konstan MW, Hillard KA, Hillard JB, Ghnaim H and Berger M: Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995, 152: 2111-2118.
84. Konstan MW, Walenga RW, Hilliard KA and Hilliard JB: Leukotriene B4 is markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993, 148: 896-901.
85. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hillard JB and Berger M: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995, 13: 257-261.
86. Bonfield TL, Konstan MW and Berger M: Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999, 104: 72-78.
87. McElvaney NG, Nakamura H, Birrer P, Hebert CA, Wong WL, Alphonso M, Baker JB, Catalano MA and Crystal RG: Modulation of airway inflammation in cystic fibrosis: In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992, 90: 1296-1301.
88. Nakamura H, Yoshimura K, McElvaney NG and Crystal RG: Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in human bronchial epithelial cell line. J Clin Invest 1992, 89: 1478-1484.
89. Sommerhoff CP, Nadel JA, Basbaum CB and Caughey GH: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990, 85: 682-689.
90. Schuster A, Ueki I and Nadel JA: Neutrophil elastase stimulates tracheal submucosa gland secretion that is inhibited by ICI 200,355. Am J Physiol 1992, 262: L86-L91.
91. Tegner H, Ohlsson K, Toremalm NG and von Mecklenbeurg C: Effect of human leukocyte enzymes on tracheal mucosa and mucociliary activity. Rhinology 1979, 17:199-206.
92. Tosi MF and Berger M: Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. J Immunol 1988, 141:2097-2103.
93. Tosi MF and Zakem H: Surface expression of Fc gamma receptor III (CD 16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J Clin Invest 1992, 90:462-470.
94. Tosi MF, Zakem H and Berger M: Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990, 86:300-308.
95. Berger M, Sorensen RU, Tosi MF, Dearborn DG and Doring G: Complement receptor expression on neutrophils at an inflammatory site, the pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989, 84:1302-1313.
96. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R and Crystal RG: Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994, 150:207-213.
97. Velsor LW, van Heeckeren A and Day BJ: Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Physiol Lung Cell Mol Physiol 2001, 281:L31-L38.